Bioprocess automation refers to the use of advanced control systems, sensors, robotics and software to monitor, manage and optimize biological manufacturing processes. These processes include cell culture, fermentation, purification and formulation in the production of biopharmaceuticals, vaccines and other biotechnology products. The primary purpose of bioprocess automation is to enhance process efficiency, consistency and product quality while reducing human error and operational costs.
The global bioprocess automation market reached a value of nearly $5,672.39 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.37% since 2019. The market is expected to grow from $5,672.39 million in 2024 to $10,237.74 million in 2029 at a rate of 12.53%. The market is then expected to grow at a CAGR of 12.02% from 2029 and reach $18,059.34 million in 2034.
Growing Demand For Personalized Medicine
During the historic period, the bioprocess automation market was mainly driven by the growing demand for personalized medicine. This demand created a strong push for automation technologies that can support rapid changeovers, precise process control and scalability in smaller production runs. Automation platforms enabled manufacturers to reduce variability and ensure consistency across highly specialized therapies, laying the foundation for wider adoption of bioprocess automation. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved a record 20 new personalized medicines, representing 38% of all new therapeutic molecular entities and marking the fourth consecutive year that personalized treatments accounted for more than a third of new drug approvals. This surge was especially significant in the rare disease category, with 16 personalized medicines approved for these conditions, more than doubling from just six approvals in 2022 and reflecting a major leap in addressing previously unmet medical needs in rare and often life-threatening genetic disorders. Therefore, the bioprocess automation market was mainly driven by the growing demand for personalized medicine.
Increasing Integration Of Artificial Intelligence And Machine Learning In Bioprocess Control
Companies operating in the bioprocess automation market are focusing on integrating artificial intelligence (AI) and machine learning (ML) into bioprocess control systems to enable predictive modelling, real-time decision-making and adaptive feedback control of upstream and downstream operations. These innovations are designed to improve yield consistency, reduce batch failures, minimize manual interventions and accelerate time-to-market while maintaining regulatory compliance and product quality. For instance, in July 2025, CPI (The Centre for Process Innovation), a UK-based technology and innovation center, joined the Canada-UK collaboration BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments), which combines real-time sensing via Nicoya, automation via Labman, AI (artificial intelligence) and digital twins via Basetwo and bioreactor technologies via CPI to deliver a demonstrator platform for AI-optimized bioreactor control for biologics manufacturing. Nicoya is a Canadian company specializing in biosensors, notably the Alto SPR biosensor. Labman Automation is a UK-based developer of automation and robotics; and Basetwo is a Canadian technology company focused on artificial intelligence and digital twin platforms.
The global bioprocess automation market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 19.55% of the total market in 2024.
Bioprocess Automation Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioprocess automation market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for bioprocess automation? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioprocess automation market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioprocess automation market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
- Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by component of process control system, by scale of operation, mode of operation and by compatibility with bioprocessing systems in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for bioprocess automation market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Component Of Process Control System: Sensors; Actuators; Controllers
- 2) By Scale Of Operation: Preclinical Operations; Clinical Operations; Commercial Operations
- 3) By Mode Of Operation: Batch; Fed-Batch; Perfusion
- 4) By Compatibility With Bioprocessing Systems: Single-Use Systems; Stainless Steel; Other Bioprocessing Systems
- Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation (Cytia); Sartorius AG; Lonza Group AG; Merck KGaA (MilliporeSigma)
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioprocess automation indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.